Tech Company Financing Transactions

Bicycle Therapeutics Funding Round

Bicycle Therapeutics secured a $51.4 million Series B financing round on 6/2/2017. Backers included Vertex Venture Capital, Atlas Accelerator and Cambridge Innovation Capital.

Transaction Overview

Announced On
6/2/2017
Transaction Type
Venture Equity
Amount
$51,400,000
Round
Series B
Proceeds Purpose
Proceeds will be used to further the development of multiple drug candidates, including Bicycle's lead molecule, BT1718, a first-in-class drug for cancers of high unmet need.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4 Hartwell Pl.
Lexington, MA 02421
USA
Phone
Undisclosed
Email Address
Overview
Bicycle Therapeutics is developing a new class of medicines to treat oncology and other important diseases based on its proprietary bicyclic peptide (Bicycle) product platform. Bicycles exhibit the affinity and exquisite target specificity usually associated with antibodies.
Profile
Bicycle Therapeutics LinkedIn Company Profile
Social Media
Bicycle Therapeutics Company Twitter Account
Company News
Bicycle Therapeutics News
Facebook
Bicycle Therapeutics on Facebook
YouTube
Bicycle Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Kevin Lee
  Kevin Lee LinkedIn Profile  Kevin Lee Twitter Account  Kevin Lee News  Kevin Lee on Facebook
Chief Financial Officer
Lee Kalowski
  Lee Kalowski LinkedIn Profile  Lee Kalowski Twitter Account  Lee Kalowski News  Lee Kalowski on Facebook
Chief Scientific Officer
Nick Keen
  Nick Keen LinkedIn Profile  Nick Keen Twitter Account  Nick Keen News  Nick Keen on Facebook
VP - Operations
Michael Skynner
  Michael Skynner LinkedIn Profile  Michael Skynner Twitter Account  Michael Skynner News  Michael Skynner on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/2/2017: Bright Health venture capital transaction
Next: 6/2/2017: Arcadia venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary